Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...

Palm reading may not foresee your future, but if you flip your hand around, it could reveal crucial information about how long you may live.

The neuroendocrine carcinoma market is experiencing steady growth driven by rising disease prevalence and improved diagnostic ...

The neuroendocrine carcinoma market is experiencing steady growth driven by rising disease prevalence and improved diagnostic capabilities. Advancements in targeted therapies and immunotherapies ...

What should oncology nurses and advanced practice providers understand about GLP-1 RAs in the care of patients with breast ...

TD Cowen 46th Annual Health Care Conference March 4, 2026 10:30 AM ESTCompany ParticipantsBrian Sullivan - Co-Founder, Chairman ...

Multiple randomized clinical trials now show that type 2 diabetes can be pushed into remission through structured weight loss ...

Publix still showed growth in 2025, albeit sluggish. The grocer listed several challenges, including inflation, tariffs and ...

Xeris Biopharma benefits from the FDA's CRL to Corcept's relacorilant, removing a major competitive threat to Recorlev sales ...

The most frequently given tip for keeping blood sugar in a healthy range is to minimize added sugar intake. It's not the ...

A 2026 Informational Overview of the BreezeMeds Compounded GLP-1 Telehealth Weight Loss Platform, Semaglutide and Tirzepatide Medication Formats, Published Pricing Structure, 503A Compounding Pharmacy ...

Dr. Marcus Coplin, a naturopathic medical doctor and the medical director of The Springs Resort in Colorado and Murrieta Hot Springs Resort in California, has released a new white paper titled Future ...